Competitive Advantages
- Inexpensive and scalable synthesis process
- Commercially available reagent used as starting product
- Provides a synthesis method for generation of novel analogs
- Quantification of minor cannabinoids
Summary
“Medical marijuana” is a hot topic but more biomedical research is needed demonstrating the health benefits the of the different cannabinoids (over 110) that have been identified in the cannabis plant. Harvesting the full medical benefits of the cannabinoids is prevented by two problems, limited supplies and incomplete knowledge of their protein targets. Most cannabinoids produced by the cannabis plant are available in small quantities, dramatically hampering research into their health benefits of these rare cannabinoids. Researchers at USF have developed methods for the synthesis of cannabinoids, potentially solving the supply problem, and methods to identify the novel protein binding partners for cannabinoids whose target is unknown. Ongoing research efforts to synthesize cannabinoids and cannabinoid-based probes will solve both the supply and target problems.
Structure of Intermediate Compound Synthesized to Yield Both CBD and THC
Desired Partnerships
- License
- Sponsored Research
- Co-Development